Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo

Immunobiology

Volumn 219, Issue 7, 2014, Pages 554-564

  Jeong, Young Joo ^a   Kim, Jin Hee ^a   Hong, Jun Man ^a   Kang, Jae Seung ^a   Kim, Hang Rae ^a   Lee, Wang Jae ^a   Hwang, Young il ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Dendritic cell vaccination; Dendritic cells; Memory cell differentiation; Vitamin C

Indexed keywords

ASCORBIC ACID; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; PADGEM PROTEIN; L SELECTIN; LIPOPOLYSACCHARIDE; VITAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; EFFECTOR CELL; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL INOCULATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COCULTURE; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PROCEDURES; SURVIVAL; TRANSPLANTATION; TUMOR CELL LINE; VACCINATION;

ANIMALS; ANTIGENS, CD44; ASCORBIC ACID; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-15; L-SELECTIN; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SURVIVAL ANALYSIS; VACCINATION; VITAMINS;

EID: 84900463625     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.03.006     Document Type: Article

References (57)

1. Ballestrero A., Boy D., Moran E., Cirmena G., Brossart P., Nencioni A. Immunotherapy with dendritic cells for cancer. Adv. Drug Deliv. Rev. 2008, 14:173-183.
2. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5:296-306.
3. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:478-480.
4. Bergamaschi C., Bear J., Rosati M., Beach R.K., Alicea C., Sowder R., Chertova E., Rosenberg S.A., Felber B.K., Pavlakis G.N. Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood 2012, 120:e1-e8.
5. + T cell homeostasis. J. Exp. Med. 2004, 200:825-834.
6. Chang H.H., Chen C.S., Lin J.Y. High dose vitamin C supplementation increases the Th1/Th2 cytokine secretion ratio, but decreases eosinophilic infiltration in bronchoalveolar lavage fluid of ovalbumin-sensitized and challenged mice. J. Agric. Food Chem. 2009, 57:10471-10476.
7. Chang J., Cho J.H., Lee S.W., Choi S.Y., Ha S.J., Sung Y.C. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J. Immunol. 2004, 172:2818-2826.
8. Curtsinger J.M., Johnson C.M., Mescher M.F. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 2003, 171:5165-5171.
9. D'Souza W.N., Schluns K.S., Masopust D., Lefrancois L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 2002, 168:5566-5572.
10. Dubick M.A., Critchfield J.W., Last J.A., Cross C.E., Rucker R.B. Ascorbic acid turnover in the mouse following acute ozone exposure. Toxicology 1983, 27:301-313.
11. + T cells to differentiate into CTL. Eur. J. Immunol. 2007, 37:1678-1690.
12. Feau S., Arens R., Togher S., Schoenberger S.P. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat. Immunol. 2011, 12:908-913.
13. Frasca L., Stonier S.W., Overwijk W.W., Schluns K.S. Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types. J. Leukoc. Biol. 2010, 88:69-78.
14. Giermasz A.S., Urban J.A., Nakamura Y., Watchmaker P., Cumberland R.L., Gooding W., Kalinski P. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunol. Immunother. 2009, 58:1329-1336.
15. + T-cell memory determined by clonal burst size. Nature 1994, 369:652-654.
16. Janelsins B.M., Mathers A.R., Tkacheva O.A., Erdos G., Shufesky W.J., Morelli A.E., Larregina A.T. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood 2009, 113:3017-3026.
17. + T lymphocytes. Nature 2003, 421:852-856.
18. Jenkins M.K., Johnson J.G. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 1993, 5:361-367.
19. Jeong Y.J., Hong S.W., Kim J.H., Jin D.H., Kang J.S., Lee W.J., Hwang Y.I. Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naïve T cells into Th1 cells by increased IL-12 secretions. Cell Immunol. 2011, 266:192-199.
20. + T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2001, 2:415-422.
21. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8T cells that give rise to long-lived memory cells. Nat. Immunol. 2003, 4:1191-1198.
22. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C., Joyce S., Peschon J.J. Reversible defects in natural killer and memory CD8T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000, 191:771-780.
23. Kim H.W., Cho S.I., Bae S., Kim H., Kim Y., Hwang Y.I., Kang J.S., Lee W.J. Vitamin C up-regulates expression of CD80, CD86 and MHC class II on dendritic cell line, DC-1 via the activation of p38 MAPK. Immune Netw. 2012, 12:277-283.
24. + T cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1969-1974.
25. Kucera A., Pýcha K., Pajer P., Spísek R., Skába R. Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma - comparison with preventive anti-tumour vaccination. Folia Biol. (Praha) 2009, 55:119-125.
26. Lee C.W., Wang X.D., Chien K.L., Ge Z., Rickman B.H., Rogers A.B., Varro A., Whary M.T., Wang T.C., Fox J.G. Vitamin C supplementation does not protect l-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy. Int. J. Cancer 2008, 122:1068-1076.
27. Lesterhuis W.J., de Vries I.J., Schreibelt G., Lambeck A.J., Aarntzen E.H., Jacobs J.F., Scharenborg N.M., van de Rakt M.W., de Boer A.J., Croockewit S., van Rossum M.M., Mus R., Oyen W.J., Boerman O.C., Lucas S., Adema G.J., Punt C.J., Figdor C.G. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin. Cancer Res. 2011, 17:5725-5735.
28. Maeng H.G., Lim H., Jeong Y.J., Woo A., Kang J.S., Lee W.J., Hwang Y.I. Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects. Immunobiology 2009, 214:311-320.
29. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G. Early programming of T cell populations responding to bacterial infection. J. Immunol. 2000, 165:6833-6839.
30. + T cells. Immunol. Rev. 2006, 211:81-92.
31. + effector and memory T cells. J. Immunol. 2010, 184:6719-6730.
32. Musso T., Calosso L., Zucca M., Millesimo M., Ravarino D., Giovarelli M., Malavasi F., Ponzi A.N., Paus R., Bulfone-Paus S. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 1999, 93:3531-3539.
33. Noh K., Lim H., Moon S.K., Kang J.S., Lee W.J., Lee D., Hwang Y.I. Mega-dose vitamin C modulates T cell functions in Balb/c mice only when administered during T cell activation. Immunol. Lett. 2005, 98:63-72.
34. Obar J.J., Lefrançois L. Early signals during CD8T cell priming regulate the generation of central memory cells. J. Immunol. 2010, 185:263-272.
35. + T cell differentiation. Ann. N. Y. Acad. Sci. 2010, 1183:251-266.
36. Pearce E.L., Shen H. Generation of CD8T cell memory is regulated by IL-12. J. Immunol. 2007, 179:2074-2081.
37. Peng S., Kim T.W., Lee J.H., Yang M., He L., Hung C.F., Wu T.C. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum. Gene Ther. 2005, 16:584-593.
38. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am. J. Clin. Nutr. 1991, 54:1135S-1140S.
39. Rückert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R., Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8T cell immune responses. Eur. J. Immunol. 2003, 33:3493-3503.
40. Sarkar S., Kalia V., Haining W.N., Konieczny B.T., Subramaniam S., Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 2008, 205:625-640.
41. Schluns K.S., Williams K., Ma A., Zheng X.X., Lefrançois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8T cells. J. Immunol. 2002, 168:4827-4831.
42. + T cells in vivo. J. Immunol. 1999, 163:2561-2567.
43. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393(6684):480-483.
44. Shedlock D.J., Shen H. Requirement for CD4T cell help in generating functional CD8T cell memory. Science 2003, 300:337-339.
45. Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240(4856):1169-1176.
46. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
47. + effector and memory T cell subsets. Cell. Mol. Immunol. 2007, 4(6):399-405.
48. Stoklasek T.A., Schluns K.S., Lefrançois L. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 2006, 177:6072-6080.
49. Stonier S.W., Ma L.J., Castillo E.F., Schluns K.S. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood 2008, 112:4546-4554.
50. + T cell differentiation. J. Immunol. 2006, 177:7515-7519.
51. + T cell memory. J. Immunol. 2007, 179:1190-1197.
52. Williams M.A., Bevan M.J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 2007, 25:171-192.
53. + memory T cells. Nature 2006, 441:890-893.
54. Woo A., Kim J.H., Jeong Y.J., Maeng H.G., Lee Y.T., Kang J.S., Lee W.J., Hwang Y.I. Vitamin C acts indirectly to modulate isotype switching in mouse B cells. Anat. Cell Biol. 2010, 43:25-35.
55. Yamaguchi S., Tatsumi T., Takehara T., Sasakawa A., Hikita H., Kohga K., Uemura A., Sakamori R., Ohkawa K., Hayashi N. Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity. Cancer Immunol. Immunother. 2008, 57:1861-1869.
56. + T cell. Eur. J. Immunol. 2011, 41:60-66.
57. Zhang S., Zhang H., Zhao J. The role of CD4 T cell help for CD8 CTL activation. Biochem. Biophys. Res. Commun. 2009, 384:405-408.